Mayo Clinic researchers in hereditary conditions (medical genetics), nervous system conditions (neurology) and other areas study causes, diagnostic tests and potential treatments for metachromatic leukodystrophy and other conditions.
Researchers study enzyme replacement therapy, gene therapy and other potential treatments for metachromatic leukodystrophy.
See a list of publications on metachromatic leukodystrophy by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.
Nov. 23, 2016
- NINDS metachromatic leukodystrophy information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/metachromatic_leukodystrophy/metachromatic_leukodystrophy.htm. Accessed Sept. 8, 2016.
- Cruse RP. Metachromatic leukodystrophy. http://www.uptodate.com/home. Accessed Sept. 8, 2016.
- Patil SA, et al. Developing therapeutic approaches for metachromatic leukodystrophy. Drug Design, Development and Therapy. 2013;7:729.
- Pagon RA, et al., eds. Arylsulfatase A Deficiency. In: GeneReviews. Seattle, Wash.: University of Seattle, Washington; 1993-2016. http://www.ncbi.nlm.nih.gov/books/NBK1116. Accessed Sept. 8, 2016.
- Neurological diagnostic tests and procedures. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/misc/diagnostic_tests.htm. Accessed Sept. 8, 2016.
- Patterson MC (expert opinion). Mayo Clinic, Rochester, Minn. September 13, 2016.